Skip to main content
SpringerLink
Log in

Intravenöses Ketamin bei therapieresistenter Depression

Ketamininfusion ein- oder zweimal pro Woche?

  • journal club
  • Published:
InFo Neurologie & Psychiatrie Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  • Singh JB, Fedgchin M, Daly EJ et al. A double-blind, randomized, placebo-controlled, dose-frequency study of intravenous ketamine in patients with treatment-resistant depression. Am J Psychiatry 2016; 173: 816 – 26

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Klinik für Psychiatrie und Psychotherapie, Universitätsmedizin der Johannes Gutenberg-Universität Mainz, Mainz, Deutschland

    Sarah Kayser M.Sc.

Authors
  1. Sarah Kayser M.Sc.
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Sarah Kayser M.Sc..

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kayser, S. Ketamininfusion ein- oder zweimal pro Woche?. InFo Neurologie 19, 20–21 (2017). https://doi.org/10.1007/s15005-017-2058-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s15005-017-2058-8

Search

Navigation